Viatris Readies Restasis Launch – So Where Are The Others?
‘No Remaining Legal Or Regulatory Barriers’ Notes F-T-M Viatris
Viatris management has confirmed plans to begin shipping its long-awaited generic Restasis product immediately. Analysts continue to speculate that the approval could remove a hurdle for other firms, if they can get their ANDAs over the line.
